You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Head and neck cancers

Dinutuximab beta for treating neuroblastoma

  • Technology appraisal guidance
  • Reference number: TA538
  • Published:  22 August 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft guidance: 1
  4. Invitation to participate
  5. Draft scope documents

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 233 KB)

    Published:
    22 August 2018

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 434 KB)

    Published:
    12 July 2018
  • Public committee slides (PDF 620 KB)

    Published:
    12 July 2018
  • Committee papers (PDF 2.63 MB)

    Published:
    12 July 2018

Draft guidance: 1

  • Draft guidance: 1

  • Appraisal consultation document (PDF 415 KB)

    Published:
    04 May 2018
  • Public committee slides ACM1 (PDF 1.13 MB)

    Published:
    04 May 2018
  • Public committee slides ACM2 (PDF 607 KB)

    Published:
    04 May 2018
  • Committee papers (PDF 15.76 MB)

    Published:
    04 May 2018

Invitation to participate

  • Final scope (PDF 102 KB)

    Published:
    26 August 2016
  • Final matrix (PDF 98 KB)

    Published:
    26 August 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 101 KB)

    Published:
    26 August 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 111 KB)

    Published:
    06 June 2016
  • Provisional matrix (pre-referral) (PDF 98 KB)

    Published:
    06 June 2016
Back to top